Toll-like receptors as targets in chronic liver diseases.
Toll-like receptors (TLRs) recognise pathogen-associated molecular patterns (PAMPs) to detect the presence of pathogens. In addition to their role in innate immunity, TLRs also play a major role in the regulation of inflammation, even under sterile conditions such as injury and wound healing. This involvement has been suggested to depend, at least in part, on the ability of TLRs to recognise several endogenous TLR ligands termed damage-associated molecular patterns (DAMPs). The liver not only represents a major target of bacterial PAMPs in many disease states but also upregulates several DAMPs following injury. Accordingly, TLR-mediated signals have been implicated in a number of chronic liver diseases. Here, we will summarise recent findings on the role TLRs and TLR ligands in the pathophysiology of liver fibrosis and cirrhosis, viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease and hepatocellular carcinoma, and highlight the potential role of TLR agonists, antagonists and probiotics for the treatment of chronic liver disease.
Mencin
A
A
Columbia University, College of Physicians and Surgeons, New York, NY, USA.
Kluwe
J
J
Schwabe
R F
RF
D018988:Bacterial Translocation; D002908:Chronic Disease; D006801:Humans; D006820:Hyaluronic Acid / Q000276:immunology; D007113:Immunity, Innate / Q000502:physiology; D008024:Ligands; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000209:etiology / Q000276:immunology* / Q000503:physiopathology; D019936:Probiotics / Q000627:therapeutic use; D015398:Signal Transduction / Q000276:immunology*; D051193:Toll-Like Receptors / Q000819:agonists / Q000037:antagonists & inhibitors / Q000276:immunology / Q000502:physiology*; D015854:Up-Regulation
D008024:Ligands; D051193:Toll-Like Receptors; D006820:Hyaluronic Acid